Skip to content

A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07766642
Enrollment
35
Registered
2026-08-14
Start date
2026-03-13
Completion date
2026-09-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficulty Focusing, Low Energy, Poor Concentration, Poor Memory

Brief summary

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily. Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

Interventions

DIETARY_SUPPLEMENTAuri Super Mushroom Daily Gummies For Kids

All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.

Sponsors

Auri Nutrition
Lead SponsorINDUSTRY
Citruslabs
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Be male or female. * Be aged 4-12. * Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory. * Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study. * Any child who is generally healthy - does not live with any uncontrolled chronic disease. * Parent(s) who are willing to follow the study protocol and support their child to complete all study actions. * Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration. * Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period. * If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months. * Has had a stable diet and sleep schedule for at least four weeks prior to the study. * Enrolled in and currently attending school at baseline and for the duration of the study period. * Resides in the United States.

Exclusion criteria

* Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia. * Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD). * Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay. * Any child diagnosed with epilepsy or a seizure disorder. * Any child diagnosed with a bleeding disorder. * Any child with any known allergies or hypersensitivities to any supplement product ingredients. * Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period. * Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Design outcomes

Primary

MeasureTime frameDescription
Change in FocusBaseline, Week 4, and Week 8Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire
Change in Cognitive PerformanceBaseline, Week 4, and Week 8Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

Secondary

MeasureTime frameDescription
Change in Parent-Reported FocusBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire
Change in Parent-Reported AttentionBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire
Change in Parent-Reported Sleep QualityBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire
Change in Parent-Reported Gut HealthBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire
Change in Parent-Reported Natural EnergyBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire
Change in Parent-Reported Overall Well-BeingBaseline, Week 2, Week 4, Week 6, and Week 8Assessed via parent-completed self-reported questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026